RhumbLine Advisers’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $3.6M | Buy |
|
|||||
|
2023
Q3 | $2.26M | Buy |
|
|||||
|
2023
Q2 | $1.86M | Buy |
|
|||||
|
2023
Q1 | $1.8M | Sell |
|
|||||
|
2022
Q4 | $2.23M | Buy |
|
|||||
|
2022
Q3 | $3.22M | Buy |
|
|||||
|
2022
Q2 | $2.63M | Buy |
|
|||||
|
2022
Q1 | $2.92M | Sell |
|
|||||
|
2021
Q4 | $5.64M | Buy |
|
|||||
|
2021
Q3 | $6.42M | Sell |
|
|||||
|
2021
Q2 | $6.01M | Sell |
|
|||||
|
2021
Q1 | $8.42M | Sell |
|
|||||
|
2020
Q4 | $11.8M | Buy |
|
|||||
|
2020
Q3 | $7.82M | Sell |
|
|||||
|
2020
Q2 | $6.47M | Buy |
|
|||||
|
2020
Q1 | $3.17M | Buy |
|
|||||
|
2019
Q4 | $4.89M | Buy |
|
|||||
|
2019
Q3 | $2.77M | Buy |
|
|||||
|
2019
Q2 | $3.45M | Buy |
|
|||||
|
2019
Q1 | $2.01M | Buy |
|
|||||
|
2018
Q4 | $1.11M | Buy |
|
|||||
|
2018
Q3 | $794K | Buy |
|
|||||
|
2018
Q2 | $827K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $88K | Buy |
|
|||||
|
2016
Q4 | $55K | Sell |
|
|||||
|
2016
Q3 | $87K | Buy |
|
|||||
|
2016
Q2 | $71K | Buy |
|
|||||
|
2016
Q1 | $237K | Buy |
|
|||||
|
2015
Q4 | $347K | Buy |
|
|||||
|
2015
Q3 | $297K | Buy |
|
|||||
|
2015
Q2 | $259K | Buy |
|